Insights
Altium (ASX: ALU): the story of a 2,100+% return
Investors who expect clockwork-like performance from super-successful publicly listed companies won’t be shareholders for very long.
Kevin Fung
February 26, 2024
Investors who expect clockwork-like performance from super-successful publicly listed companies won’t be shareholders for very long.
One company that embodies the advantages of both healthcare and software is Pro Medicus (ASX: PME).
Amazon released its Q4-2023 results last Friday, with a record-breaking Holiday shopping season resulting in the best ever quarter in company history.
Xero Limited (ASX: XRO) is akin to teenage wonderkid. The business isn’t even an adult (it turns 18 next year) but has emerged as the dominant provider of small business accounting software in ANZ, with more growth promised in overseas markets.
Commonwealth Bank (ASX: CBA) is somewhat of a battleground ASX share. Income investors adore the reliable and regular dividends.
Unless you’re an electrical engineer, it’s unlikely you’ve come across Altium Limited (ASX: ALU). Altium builds and sells software used to design printed circuit boards (PCBs).
We’ve made meaningful changes to all portfolios.
CSL Limited (ASX: CSL) is one of the most revered companies by Australian investors. The pharmaceutical giant has an enviable track record of earnings growth dating back to its privatisation in 1994.
Impressively, homegrown hearing implant pioneer Cochlear (ASX: COH) has outpaced that number, returning nearly 18% per year since listing in 1995.
Wesfarmers (ASX: WES) has built a reputation as the quintessential bottom draw stock. Over the past five, ten and 25 years the Perth-based conglomerate has outperformed the broader market.
Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
